Patrick Aebischer
51Patents
34h-index
50Co-inventors
91Inventor score
Filing activity: Mar 30, 1987 → Mar 4, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5554148A | Renewable neural implant device and method | Chemistry; Metallurgy | 1,434 | Expired |
| US6083523A | Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products | Chemistry; Metallurgy | 442 | Expired |
| US4892538A | In vivo delivery of neurotransmitters by implanted, encapsulated cells | Chemistry; Metallurgy | 392 | Expired |
| US5011472A | Implantable delivery system for biological factors | Human Necessities | 291 | Expired |
| US5487739A | Implantable therapy systems and methods | Chemistry; Metallurgy | 290 | Expired |
| US5106627A | Neurological therapy devices | Chemistry; Metallurgy | 196 | Expired |
| US5283187A | Cell culture-containing tubular capsule produced by co-extrusion | Chemistry; Metallurgy | 165 | Expired |
| US5158881A | Method and system for encapsulating cells in a tubular extrudate in separate cell compartments | Chemistry; Metallurgy | 147 | Expired |
| US5858747A | Control of cell growth in a bioartificial organ with extracellular matrix coated microcarriers | Chemistry; Metallurgy | 145 | Expired |
| US5800828A | Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products | Chemistry; Metallurgy | 138 | Expired |
| US5871767A | Methods for treatment or prevention of neurodegenerative conditions using immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core | Chemistry; Metallurgy | 126 | Expired |
| US5284761A | Method of encapsulating cells in a tubular extrudate | Chemistry; Metallurgy | 121 | Expired |
| US5474547A | Implanting devices for the focal release of neuroinhibitory compounds | Chemistry; Metallurgy | 107 | Expired |
| US5182111A | In vivo delivery of active factors by co-cultured cell implants | Chemistry; Metallurgy | 101 | Expired |
| US5798113A | Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products | Chemistry; Metallurgy | 99 | Expired |
| US5776747A | Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer | Chemistry; Metallurgy | 98 | Expired |
| US4878913A | Devices for neural signal transmission | Human Necessities | 95 | Expired |
| US6179826A | Implantable therapy systems and methods | Chemistry; Metallurgy | 93 | Expired |
| US5156844A | Neurological therapy system | Chemistry; Metallurgy | 85 | Expired |
| US5795790A | Method for controlling proliferation and differentiation of cells encapsulated within bioartificial organs | Chemistry; Metallurgy | 81 | Expired |
| US6156572A | Bioartificial extracellular matrix containing hydrogel matrix derivatized with cell adhesive peptide fragment | Emerging Cross-Sectional Technologies | 77 | Expired |
| US5834029A | Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment | Emerging Cross-Sectional Technologies | 74 | Expired |
| US5011486A | Composite nerve guidance channels | Human Necessities | 68 | Expired |
| US5935849A | Methods and compositions of growth control for cells encapsulated within bioartificial organs | Chemistry; Metallurgy | 55 | Expired |
| US5834001A | Methods for making immunoisolatory implantable vehicles with a biocompatiable jacket and a biocompatible matrix core | Chemistry; Metallurgy | 53 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.